long-acting interferon drug product company in Hepatitis and Cytokines

Home / About Us

About Amoytop Biotech

National innovation team in priority area

Core technology platforms

Launched drug products

National Major Scientific and Technological Special Projects for Significant New Drug Development

Xiamen Amoytop Biotech Co., Ltd. is an innovative biopharmaceutical company and a listed company on the Science and Technology Innovation Board (SSE STAR Market) in China, specializing in R&D, manufacturing and marketing of regular and long-acting recombinant protein drugs. Focusing on the R&D of immune-related cytokine medicines, Amoytop Biotech is committed to becoming a leader in solving cytokine medicine-based systemic immune problems, providing better solutions for major diseases (such as viral hepatitis, malignant tumors) and immunotherapy.

Targeting major diseases and immunotherapy fields, Amoytop Biotech has built an innovation platform covering the expression, long-acting modification and industrialization of various protein drugs, and owned the innovation ability in fundamental research, pilot-scale research, clinical study and industrialization research. Now, Amoytop Biotech has established national post-doctoral workstation and national-local joint research center, and has been awarded as a national innovation-oriented enterprise that has advantages in national intellectual property. Moving forward, Amoytop Biotech will continue to explore diverse innovation mechanisms and comprehensive solutions leveraging synergistic product combinations in targeting disease areas, aiming to provide customers with more diversified and effective therapeutic solutions.

"Specialized in R&D and production of recombinant protein drugs, committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy"

Company Culture

Vision

To be a Leading International Biopharmaceutical Company in China

Mission

Devoted to Constant Innovation in Biopharmaceutical Field for a Better and Healthier Life for Human

Core Value

Responsibility丨Fairness丨Performance丨Win-Win

Milestones

2025
2023
2020
2016
2014
2012
2011
2010
2008
2005
2004
2002
1999
1997
1996

2025

Pegpesen ®（Pegsomatropin Injection）Launched，National Class 1 new drug.
2023

Pegneugen ® (Pegfilgrastim) Launched, National Class 1 New Drug
2020

Listed on SSE STAR Market (Sci-tech innovation board, Shanghai Stock Exchange), the first biomedical stock from Fujian Province
2016

Launched PEGBING® (Peginterferon alfa-2b), a national class 1 new drug
2014

Approved as “National Innovation Team in Priority Fields” by Ministry of Science and Technology
2012

Approved as "Key High-Tech Enterprises of National Torch Program”
2011

Approved as“National-Local Joint Research Center”
2010

Awarded“National Innovation-Oriented Enterprise”
2008

Established postdoctoral research station
2005

Launched TOPMEGA® (rHuIL-11)
2004

Undertook the Demonstration Project of Industrialization and Internationalization of Genetically Engineered Protein Drugs for National Development and Reform Committee, China
2002

Founded wholly-owned research institute,“Xiamen Biosteed Gene Transformation Tech. Co. ,Ltd.”
1999

Launched TOPNEUTER® (rHuG-CSF)
1997

Launched TOPLEUCON® (rHuGM-CSF), the first China-made GM-CSF
1996

Founded Amoytop Biotech

Awards and Honors

National Innovation-Oriented Enterprise

Drug Technology Innovation Platform

Innovation Team in Priority Fields

National Enterprise with Competitive Intellectual Property Advantages

2017 Excellent Product Brand of China's Pharmaceutical Industry Biochemical Products Sector

National Innovation Team

in Priority Fields

Hi-tech Enterprise

National-Local Joint Research Center

Social Responsibility

Great ships require deep waters; swift horses cover great distances. “Realizing the value of technology and knowledge by transforming them into products and services to benefit patients” is the initial mission and intention insisted on by Amoytop Biotech. As a pharmaceutical enterprise, promoting the development of the biomedical industry and providing a healthier life for more patients are the main social responsibility of Amoytop Biotech.